What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French Health Insurance Database.
2021
The inherent risk of agranulocytosis associated with clozapine requires the realization of weekly white blood cell monitoring (WBCM) during the 18 first weeks of treatment. The aim of this study wa...
-
Correction
-
Source
-
Cite
-
Save
27
References
0
Citations
NaN
KQI